Cinical trials:
Various randomized multicentre international phase III clinical trials and randomized bioequivalence studies
Memberships:
1. Multinational association for supportive care in cancer (MASCC)
2. European Society for Medical Oncology (ESMO)
3. Serbian Medical Society-general secretary
4. Serbian Society of Medical Oncology
5. European Association for Cancer Research (EACR)
6. Serbian Association for Cancer Research (SDIR)
7. Society of Hematologic Oncology (SOHO) – Ambassador to Serbia
Publications:
I Abstracts from International congresses /Abstract Books/:
1. Nikolić V, Josifovski J, Radosavljević D, Nikolić N, Ristić M, Djordjević F, Čavić M, Jakovljević K, Janković R, Gavrilović D:
Efficasy of the combination of Irinotecan and Cetuximab in treating patients with chemotherapy refractory metastatic colorectal cancer- preliminary results- Arch.of Gastroenterohepatology, oct 2011,Vol.28, No1-2,p.104,PP32
2. Spasić J, Krivokuća, A, Čavić, M, Jakovljević, K, Mališić E, Ristić, M, Djordjević F, Radosavljević D, Janković R.
Thymidylate synthase gene polymorphisms and lung adenocarcinoma in Serbia. 3rd European Lung Cancer Conference. J Thorac Oncol. 2012,7(6), Supplement 1:S42 (abstract id. 113P)
3. Spasić J, Stanic N, Djordjević F, Ristić M, Nikolić N, Radosavljević D.
Is there an association between the occurrence of neutropenia and neuropathy in patients with metastatic colorectal cancer treated with Folfox Ann Oncol (2013) 24 (suppl 4): iv97
4. J.Dimitrijevic , S.Bosnjak, F.Djordjevic, N.Bakic, I.Kezic. The Edmonton Symptom Assessment System (ESAS) as a screening tool for symptoms in patients admitted to Clinic for medical oncology, Instutute for oncology and radiology of Serbia. 2nd Regional Congress on Supportive Care in Oncology. Abstract book (2014)
5. Djordjevic F, Bosnjak S, Dimitrijevic J, Stanic N, Bakic N, Susnjar S. Hydromorphone SR effective and safe for the treatment of cancer dyspnea in lung cancer patients: positive preliminary results. Support Care Cancer 2015, 23 (Suppl 1): S260
6. Spasic J, Stanic,N, Ristic M, Djordjevic F , Nikolic N, Nikolic V, Pupovac S, Radosavljevic,D. (2015). Cetuximab as third line treatment of metastatic colorectal carcinoma (mCRC) – 5-year experience from the Institute of Oncology and Radiology of Serbia. Annals of Oncology. 26. 10.1093/annonc/mdv233.276.
7. Bosnjak S, Dimitrijevic J, Djordjevic F. Cancer and Chemotherapy-induced Nausea and Vomiting: A focus on olanzapine. Current Opinion in Supportive & Palliative Care (2016), 10:180–188
8. Scientific Days of the Oncology Institute, May 2017,Bucharest, Romania- abstract book: F.Djordjevic. Serbian model of integration of Palliative care into Oncology practice
9. Spasic J, Stanic N, Djordjevic F , Ristic M, Nikolić V, Radosavljevic, Davorin. (2017). Mitomycin-c (mtc) as salvage therapy for patients with metastatic colorectal cancer (mCRC). Annals of Oncology. 28. 10.1093/annonc/mdx261.321
10. Spasic, J,Stanic, N, Djordjevic F, Jokic V Radosavljevic D (2018). P3.01-92 Blood Test Parameters as Prognostic Factors In EGFR-Mutated Non-Small Cell Lung Cancer Treated With TKIs. Journal of Thoracic Oncology. 13. S902. 10.1016/j.jtho.2018.08.1652.
11. Radosavljevic D, Spasic J, Ristic M , Nikolic V , Nikolic N, Stanic, N. , Djordjevic F, Gavrilović, Dušica. (2018). P3.01-85 Real-World Gefitinib 1st Line Treatment of Patients with Advanced NSCLC and EGFR Mutations – Serbian Single Center Experience. Journal of Thoracic Oncology. 13. S899. 10.1016/j.jtho.2018.08.1645.
12. Djordjevic F. Assessment of Symptom Burden Among Patients Diagnosed with Multiple Myeloma (MM) Admitted to Receive Chemotherapy at the Institute for Oncology and Radiology of Serbia (IORS) (2018) Clinical Lymphoma, Myeloma and Leukemia, Volume 18, S238
II Abstracts from National congresses /Abstract Books/:
1. Section of oncology of Serbian Medical Society 52 th annual meeting, abstract book: F.Djordjevic. Dyspnea in advanced cancer patients: ESMO Clinical Practice Guidelines (2015)
2. Serbian Society of Medical Oncology School (lung cancer), abstract book: F.Djordjevic. Dyspnea in patients with lung cancer (2016)
3. 7th Serbian-French Oncology Congress, March 2016 Novi Sad, Serbia- abstract book: Morphine: Cancer Pain and Dyspnoea
4. Section of oncology of Serbian Medical Society 53 th annual meeting, abstract book: J.Dimitrijevic, S.Bosnjak, F.Djordjevic, N.Bakic, I.Kezic.The Edmonton Symptom Assessment System (ESAS) as a screening tool for symptoms in patients with melanoma admitted to Clinic for medical oncology (CMO), Instutute for oncology and radiology of Serbia (IORS) (2016)
5. Section of oncology of Serbian Medical Society 54 th annual meeting, Belgrade, Serbia, November 2017- abstract book: Djordjevic F, Stanic N, Dimitrijevic J, Spasic J, Zilic A, Bosnjak S, Radosavljevic D, Susnjar S. The efficacy and tolerability of slow release hydromorphone in the treatment of cancer dyspnea in lung cancer patients: experience from the Institute for Oncology and Radiology of Serbia
6. Serbian Society of Medical Oncology School (lung cancer), abstract book: F.Djordjevic. Immunotherapy in the first line treatment in patient with NSCLC (2018)
III Books and Monographies/Brochures:
1. Educational brochure for patients about prevention and therapy of chemotherapy induced nausea and vomiting for Serbian Society for the Fight Against Cancer (2015)
2. Educational brochure for patients about supportive oncology for Institute for oncology and radiology of Serbia (2015)